APVO Stock Analysis: Buy, Sell, or Hold?
APVO - Aptevo Therapeutics Inc
$5.21
-0.07 (-1.33%)
▼
5d:
+9.92%
30d:
+15.78%
90d:
-44.84%
BUY
MODERATE Confidence
Analysis Updated: Apr 20, 2026 12:00 AM ET
Earnings: May 21, 2026
29d
Get Alerted When APVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: APVO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: APVO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: APVO is currently trading at $5.21, which is considered extended relative to its 30-day fair value range of $4.15 to $4.98.
Technical Outlook: Technically, APVO is in a uptrend. Immediate support is located at $3.80, while resistance sits at $5.69.
Market Sentiment: APVO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.00 (+303.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, APVO is in a uptrend. Immediate support is located at $3.80, while resistance sits at $5.69.
Market Sentiment: APVO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.00 (+303.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$4.15 -
$4.98
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 303.1% below Wall St target ($21.00)
Fair Price Analysis
30-Day Fair Range
$4.15 -
$4.98
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$3.80
Resistance Level
$5.69
Current Trend
Uptrend
Technical data as of
Apr 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.28
Wall Street Target
$21.00
(+303.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: April 21, 2026 4:55 AM ET
Data refreshes hourly during market hours. Next update: 5:55 AM
Data refreshes hourly during market hours. Next update: 5:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 64 BUY |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 60 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 66 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 63 BUY |
